Birla Fertility & IVF, one of India’s largest IVF networks, has elevated distinguished fertility specialist Dr. K.U. Kunjimoideen as Medical Director, strengthening clinical governance, evidence-based protocols and consistent patient care across its network of 51+ centres in 38 cities and 18 states. Previously serving as Regional Medical Director, Dr. Kunjimoideen will now oversee the organisation’s clinical function nationwide, with responsibility for clinical quality, medical governance, treatment protocols, laboratory excellence, patient outcomes and standardisation across all centres.
With over 28 years of experience in reproductive medicine, assisted reproductive technology and complex infertility management, Dr. K.U. Kunjimoideen has held several leadership positions, including Chairperson of the Kerala Chapter of the Indian Society for Assisted Reproduction, President of the Kerala Federation of Obstetrics and Gynaecology, Founding Secretary of the Indian Fertility Society Kerala Chapter, Joint Secretary of the Indian Fertility Society and President of the Perinthalmanna Obstetrics and Gynaecology Society. Mr. Abhishek Aggrawal, CEO, Birla Fertility & IVF, said the appointment will further strengthen clinical leadership and ensure consistent, safe, ethical and outcome-driven fertility care across the organisation’s expanding network.
A CK Birla Healthcare company and part of the CKA Birla Group, Birla Fertility & IVF began operations in 2020 and has completed over 1,40,000 IVF cycles, serving more than 2.3 lakh patients with a 95% patient satisfaction rate and a commitment to transparency and affordability. The organisation offers IVF, ICSI, IUI, FET, Blastocyst Culture, male and female infertility treatments, Cancer Fertility Preservation, PGS and PGD, supported by advanced IVF laboratories, dedicated embryology units and multidisciplinary fertility specialists. Birla Fertility & IVF has also received recognitions including the FICCI Healthcare Excellence Award, IHW Silver Award for Excellence in ART & IVF 2024 and the ET Healthworld National Fertility Award 2025 for ‘Best IVF Chain of the Year (East)’.